期刊文献+

Clinical significance of occult hepatitis B virus infection 被引量:6

Clinical significance of occult hepatitis B virus infection
下载PDF
导出
摘要 Occult hepatitis B virus(HBV) infection(OBI) is defined as the presence of HBV DNA in the liver(with or without detectable HBV DNA in serum) for individuals testing HBV surface antigen negative.Until recently,the clinical effect of OBI was unclear on the progression of liver disease;on the development of hepatocellular carcinoma;and on the risk for reactivation or transmission of HBV infection.Several studies suggest a high prevalence of OBI among patients with cryptogenic chronic liver disease,but its role in the progression to cirrhosis remains unclear.Although OBI has been well documented in human immunodeficiency virus(HIV) -positive patients,especially among those coinfected with hepatitis C virus,further studies are needed to determine its current clinical impact in HIV setting. Occult hepatitis B virus(HBV) infection(OBI) is defined as the presence of HBV DNA in the liver(with or without detectable HBV DNA in serum) for individuals testing HBV surface antigen negative.Until recently,the clinical effect of OBI was unclear on the progression of liver disease;on the development of hepatocellular carcinoma;and on the risk for reactivation or transmission of HBV infection.Several studies suggest a high prevalence of OBI among patients with cryptogenic chronic liver disease,but its role in the progression to cirrhosis remains unclear.Although OBI has been well documented in human immunodeficiency virus(HIV) -positive patients,especially among those coinfected with hepatitis C virus,further studies are needed to determine its current clinical impact in HIV setting.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第12期1549-1552,共4页 世界胃肠病学杂志(英文版)
基金 Supported by CIBERehd is funded by the Instituto de Salud Carlos Ⅲ
关键词 Occult hepatitis B virus infection Liver dis-ease Cryptogenic cirrosis Hepatitis B virus coinfection Human immunodeficiency virus 秘密肝炎 B 病毒感染;肝疾病;起因不明的 cirrosis;肝炎 B 病毒 coinfection;人的免疫不全病毒
  • 相关文献

参考文献2

二级参考文献17

  • 1[1]Chazouilleres O,Mamish D,Kim M,Carey K,Ferrell L,Roberts JP,Ascher NL,Wright TL."Occult" hepatitis B virus as source of infection in liver transplant recipients.Lancet 1994;343:142-146 被引量:1
  • 2[2]Tai DI,Chung ZJ,Chen CL,Eng HL.Reappearance of HBsAg with compartmentalized different HBV strains in allograft versus PBMC of the recipient.J Gastroenterol 2001; 36:200-205 被引量:1
  • 3[3]Ghany MG,Ayola B,Villamil FG,Gish RG,Rojter S,Vierling JM,Lok AS.Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.Hepatology 1998; 27:213-222 被引量:1
  • 4[4]Iannitto E,Minardi V,Calvaruso G,Mule A,Ammatuna E,Di Trapani R,Ferraro D,Abbadessa V,Craxi A,Di Stefano R.Hepatitis B virus reactivation and alemtuzumab therapy.Eur J Haematol 2005; 74:254-258 被引量:1
  • 5[5]Davis CL,Gretch DR,Carithers RL Jr.Hepatitis B and transplantation.Infect Dis Clin North Am 1995; 9:925-941 被引量:1
  • 6[6]Huo TI,Wu JC,Lee PC,Chau GY,Lui WY,Tsay SH,Ting LT,Chang FY,Lee SD.Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.Hepatology 1998; 28:231-236 被引量:1
  • 7[7]Zhang YY,Nordenfelt E,Hansson BG.Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection.Scand J Infect Dis 1996; 28:9-15 被引量:1
  • 8[8]Liang TJ,Baruch Y,Ben-Porath E,Enat R,Bassan L,Brown NV,Rimon N,Blum HE,Wands JR.Hepatitis B virus infection in patients with idiopathic liver disease.Hepatology 1991; 13:1044-1051 被引量:1
  • 9[9]Chung HT,Lai CL,Lok AS.Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.Hepatology 1995; 22:25-29 被引量:1
  • 10[10]Paterlini P,Gerken G,Nakajima E,Terre S,D'Errico A,Grigioni W,Nalpas B,Franco D,Wands J,Kew M.Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen.N Engl J Med 1990; 323:80-85 被引量:1

共引文献12

同被引文献32

  • 1鲁凤民,王杰,杨紫伟,李彤,庄辉.乙型肝炎表面抗原检测技术演变及对隐匿性乙型肝炎病毒感染实验室检测的思考[J].中国医学前沿杂志(电子版),2013,5(7):3-7. 被引量:3
  • 2庄辉.乙型肝炎流行病学研究进展[J].中国医学前沿杂志(电子版),2009,1(2):18-24. 被引量:90
  • 3Kiyotaka Fujise,Keiko Tatsuzawa,Midori Kono,Sadayori Hoshina,Akihito Tsubota,Minoru Niiya,Yoshihisa Namiki,Norio Tada,Hisao Tajiri.A mutation of the start codon in the X region of hepatitis B virus DNA in a patient with non-B,non-C chronic hepatitis[J].World Journal of Hepatology,2011,3(2):56-60. 被引量:3
  • 4Zeinab N Said,Manal H El Sayed,Iman I Salama,Enas K Aboel-Magd,Magda H Mahmoud,Maged El Setouhy,Faten Mouftah,Manal B Azzab,Heidi Goubran,Amal Bassili,Gamal E Esmat.Occult hepatitis B virus infection among Egyptian blood donors[J].World Journal of Hepatology,2013,5(2):64-73. 被引量:5
  • 5FuminakaSugauchi,YasuhitoTanaka,ShigeruKusumoto,KentaroMatsuura,MasayaSugiyama,FuatKurbanov,RyuzoUeda,MasashiMizokami.Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy[J].J Med Virol.2011(3) 被引量:1
  • 6KoseiMatsue,Shun‐IchiKimura,YokoTakanashi,Kan‐IchiIwama,HideakiFujiwara,MasayukiYamakura,MasamiTakeuchi.Reactivation of hepatitis B virus after rituximab‐containing treatment in patients with CD20‐positive B‐cell lymphoma[J].Cancer.2010(20) 被引量:1
  • 7Masaya Sugiyama,Yasuhito Tanaka,Fuat Kurbanov,Isao Maruyama,Takashi Shimada,Satoru Takahashi,Tomoyuki Shirai,Keisuke Hino,Isao Sakaida,Masashi Mizokami.Direct Cytopathic Effects of Particular Hepatitis B Virus Genotypes in Severe Combined Immunodeficiency Transgenic With Urokinase-Type Plasminogen Activator Mouse With Human Hepatocytes[J].Gastroenterology.2009(2) 被引量:1
  • 8H.L.Zaaijer,P.Torres,A.Onta?ón,L. GonzálezPonte,M.H.G.M.Koppelman,P.N.Lelie,F.J.vanHemert,H.J.Boot.Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection[J].J Med Virol.2008(8) 被引量:1
  • 9Nathalie Schnepf,Pierre Sellier,Marc Bendenoun,Jean-Marc Zini,Marie-José Sanson-le pors,Marie-Christine Mazeron.Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy[J].Journal of Clinical Virology.2007(1) 被引量:1
  • 10Catherine Chakvetadze,Firouzé Bani-Sadr,Catherine Le Pendeven,Franck Lamontagne,Jean Paul Vincensini,Gilles Pialoux.Reactivation of hepatitis B virus replication during peginterferon–ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies[J].AIDS.2007(3) 被引量:1

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部